Kanglin Biotechnology (Hangzhou) Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Kanglin Biotechnology (Hangzhou) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Β-Thalassemia Treatment with KL003 Cell Injection (NCT06280378) | Kanglin Biotechnology (Hangzhou) Co., Ltd. | 2024-04-05 |
Track Kanglin Biotechnology (Hangzhou) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.